Wahane, V.D
Medical consultations at Belle are provided through Belle Health, LLC
Semaglutide, a GLP-1 receptor agonist, was administered subcutaneously at a dose of 0.052 mg/kg/day for 4 weeks, starting 4 weeks after PAB
No FDA-approved prescribing information exists for these compounds
In the left panel, I'm depicting omeprazole partially failing to treat patients' GERD because not all of its granules can pass through the stomach and into the small intestine, where it's absorbed (even with its enteric-coated granules protecting the unstable molecule in an acidic environment)
While it is primarily used to treat growth hormone deficiency, some adults may benefit from Sermorelin if they have clinically low growth hormone levels, which can affect metabolism, energy, and body composition